Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Sondel

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
The Cancer Journal From Scientific American|February 11, 1998
Combination therapy with interleukin-2 and antitumor monoclonal antibodiesP M Sondel, J A Hank
Cancer|February 1, 1990
Lymphokines and cytokines as cancer treatment. Immunotherapy realizedE C Borden, P M Sondel
Cancer Surveys|January 1, 1989
The role of interleukin-2 in cancer therapyP C Kohler, P M Sondel
Advances in Pediatrics|January 1, 1994
Immunotherapy for infection and malignancy in children with cancerJ D Frost, P M Sondel
Journal of Biological Response Modifiers|June 1, 1985
Recombinant DNA-derived interferons-alpha and -beta modulate the alloactivated proliferative response of bulk and cloned human lymphocytesB P Chen, P M Sondel
Hematology/Oncology Clinics of North America|October 26, 2001
Antibody-directed, effector cell-mediated tumor destructionP M Sondel, J A Hank
Birth Defects Original Article Series|January 1, 1973
Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivityP M Sondel, F H Bach
Tissue Antigens|March 1, 1976
Recognitive specificity of human cytotoxic T lymphocytes. II. The non-recognition of antigens controlled outside the major histocompatibility complexP M Sondel, F H Bach
Transplantation Proceedings|March 1, 1980
The alienation of tumor immunity: alien-driven diversity and alien-selected escapeP M Sondel, F H Bach
Current Opinion in Oncology|December 1, 1990
Problems, controversies, and perspectives on the clinical use of interleukin-2C Gambacorti-Passerini, P M Sondel
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
The Cancer Journal From Scientific American|February 11, 1998
Combination therapy with interleukin-2 and antitumor monoclonal antibodiesP M Sondel, J A Hank
Cancer|February 1, 1990
Lymphokines and cytokines as cancer treatment. Immunotherapy realizedE C Borden, P M Sondel
Cancer Surveys|January 1, 1989
The role of interleukin-2 in cancer therapyP C Kohler, P M Sondel
Advances in Pediatrics|January 1, 1994
Immunotherapy for infection and malignancy in children with cancerJ D Frost, P M Sondel
Journal of Biological Response Modifiers|June 1, 1985
Recombinant DNA-derived interferons-alpha and -beta modulate the alloactivated proliferative response of bulk and cloned human lymphocytesB P Chen, P M Sondel
Hematology/Oncology Clinics of North America|October 26, 2001
Antibody-directed, effector cell-mediated tumor destructionP M Sondel, J A Hank
Birth Defects Original Article Series|January 1, 1973
Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivityP M Sondel, F H Bach
Tissue Antigens|March 1, 1976
Recognitive specificity of human cytotoxic T lymphocytes. II. The non-recognition of antigens controlled outside the major histocompatibility complexP M Sondel, F H Bach
Transplantation Proceedings|March 1, 1980
The alienation of tumor immunity: alien-driven diversity and alien-selected escapeP M Sondel, F H Bach
Current Opinion in Oncology|December 1, 1990
Problems, controversies, and perspectives on the clinical use of interleukin-2C Gambacorti-Passerini, P M Sondel
Pageof 22